Sector 5 Digital Secures Mid‑Six‑Figure 3D Anatomy Training Contract with Global Pharma

VRAR
February 25, 2026

Sector 5 Digital, a subsidiary of The Glimpse Group, secured a mid‑six‑figure contract to provide a 3D anatomy training platform for a global pharmaceutical company. The agreement is a follow‑on with the client, indicating continued confidence in the company’s immersive technology.

The deal adds a high‑margin, recurring revenue stream to the company’s immersive technology division, which already includes the defense‑focused Spatial Core product. The new contract expands the company’s footprint in the medical education market and provides a foothold for future upsell opportunities.

While the contract’s value is modest relative to the company’s overall revenue—Q2 FY2025 revenue was $3.17 million and Q1 FY2026 revenue was $1.40 million—it represents a meaningful addition to a business that has been seeking to diversify beyond defense contracts. The recurring nature of the agreement also offers a tailwind against the headwinds created by U.S. government budget delays that impacted the company’s defense revenue in the first quarter of FY2026.

CEO Lyron Bentovim has emphasized the company’s strategy to unlock shareholder value through commercial expansion and AI‑driven solutions. The contract win aligns with the company’s broader focus on building a high‑margin, recurring revenue portfolio and supports the planned spin‑off of Brightline Interactive, which will allow The Glimpse Group to concentrate on its commercial initiatives such as the Foretell AI platform.

The contract underscores the growing demand for immersive training solutions in the pharmaceutical sector and signals that The Glimpse Group’s technology is gaining traction beyond its traditional defense customer base.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.